Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction of Monovisc 88mg Injection:
Monovisc 88mg Injection is a medication used for the treatment of pain associated with osteoarthritis. This medication is typically prescribed when a patient does not respond to other conventional treatments. It works by reducing friction in the joints and decreasing pain and swelling.
Monovisc 88mg Injection is administered via intra-articular injection. This involves inserting a needle into the space within the knee joint that contains fluid used for lubrication and cushioning. It should not be self-administered and can only be administered by a qualified doctor. While undergoing treatment with this medication, it is advisable to avoid activities such as strenuous sports and exercise, or prolonged standing.
Uses of Monovisc 88mg Injection:
Treatment of Osteoarthritis
Benefits of Monovisc 88mg Injection:
In the treatment of Osteoarthritis:
Osteoarthritis is a condition characterized by pain and swelling in the joints of the hands, knees, hips, and spine. Monovisc 88mg Injection is primarily used to treat knee pain caused by osteoarthritis. It helps restore synovial fluid, which lubricates and cushions the joint during movement. This restoration of fluid helps improve mobility and reduces pain. Mild symptoms of osteoarthritis can sometimes be managed with light exercises, weight loss, and appropriate footwear.
Mechanism of action of Monovisc 88mg Injection:
Monovisc 88mg Injection contains the salt form of hyaluronic acid. It supplements the viscous properties of the fluid in the knee joint, thereby reducing friction in the joints and promoting smooth joint movement.